Erika K Graul , APN
Nurse Practitioner • Carson City, NV
200 Bath St, Ste 1
Carson City, NV 897032459
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 29, 2007; this date does not establish years in practice.
-
Published CMS data list 1,368 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Albuterol Sulfate Hfa (Albuterol Sulfate) — 348 prescription fills, including refills.
- Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) — 242 prescription fills, including refills.
- Prednisone — 105 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner in Carson City, NV (2024, 21 clinicians with data). Median for this group: 688. Middle half: 327 to 1,784.
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in Nevada (2024, 459 clinicians with data). Median for this group: 388. Middle half: 87 to 1,542.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,692 in 2020 to 1,368 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
200 Bath St
Ste 1
Carson City, NV 897032459
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,971 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$454,263 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,890.85 across 88 records.
By nature of payment
- Food and Beverage: $1,834.86 across 87 records.
- Education: $55.99 across 1 record.
Reporting-company totals (3 largest of 18)
- GlaxoSmithKline, LLC.: $476.79 across 28 records.
- AstraZeneca Pharmaceuticals LP: $256.79 across 11 records.
- Regeneron Pharmaceuticals, Inc.: $228.68 across 8 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Erika Graul has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Erika Graul as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Carson City and Nevada
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner in Carson City, NV (2024, 21 clinicians with data). Median for this group: 688. Middle half: 327 to 1,784.
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in Nevada (2024, 459 clinicians with data). Median for this group: 388. Middle half: 87 to 1,542.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Nurse Practitioner in Carson City, NV (2024, 21 clinicians with data). Median for this group: $60,974. Middle half: $10,569 to $233,762.
A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner in Nevada (2024, 459 clinicians with data). Median for this group: $17,099. Middle half: $1,291 to $124,956.
31 active clinicians are listed under Nurse Practitioner with a practice address in Carson City, NV (907 in Nevada).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Carson City
19.4% of these 31 clinicians have the CMS telehealth indicator.
71% of these 31 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 19% from 1,692 in 2020 to 1,368 in 2024.
- 2020: 1,692
- 2021: 1,717
- 2022: 1,583
- 2023: 1,509
- 2024: 1,368
-
30-day fills
30-day fills decreased 11% from 2,213 in 2020 to 1,971 in 2024.
- 2020: 2,213
- 2021: 2,381
- 2022: 2,218
- 2023: 2,104
- 2024: 1,971
-
Part D drug cost
Part D drug cost decreased 18% from $551,833 in 2020 to $454,263 in 2024.
- 2020: $551,833
- 2021: $643,617
- 2022: $586,944
- 2023: $587,551
- 2024: $454,263
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 22% from $1,545.42 in 2021 to $1,890.85 in 2025.
- 2021: $1,545.42
- 2022: $1,554.89
- 2023: $1,528.36
- 2024: $1,666.58
- 2025: $1,890.85
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 88 records totaling $1,890.85.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sanofi and Genzyme US Companies |
Education
In-kind items and services
|
DUPIXENT | General | $55.99 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $48.49 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $34.05 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $33.88 |
| Tactile Systems Technology Inc |
Food and Beverage
In-kind items and services
|
Flexitouch Plus | General | $32.48 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.22 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $31.00 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
GLASSIA | General | $30.98 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $30.93 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.85 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.59 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $29.98 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.07 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.07 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.07 |
| Inspire Medical Systems, Inc. |
Food and Beverage
In-kind items and services
|
INSPIRE | General | $28.34 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.01 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $27.27 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.19 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $26.54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JASCAYD | General | $26.50 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $26.47 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
ILLUMISITE | General | $26.40 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.18 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.84 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Albuterol Sulfate Hfa | Albuterol Sulfate | 348 | 12,291 | $14,101.98 | 116 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 242 | 10,916 | $222,372.65 | 54 |
| Prednisone | Prednisone | 105 | 3,641 | $467.86 | 46 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 101 | 3,750 | $76,261.92 | 20 |
| Montelukast Sodium | Montelukast Sodium | 87 | 6,119 | $922.17 | 26 |
| Azithromycin | Azithromycin | 59 | 1,401 | $311.50 | 29 |
| Ventolin Hfa | Albuterol Sulfate | 50 | 1,877 | $4,386.39 | 23 |
| Breo Ellipta | Fluticasone/Vilanterol | 49 | 2,010 | $25,364.49 | — |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 49 | 2,040 | $28,989.91 | 12 |
| Advair Diskus | Fluticasone Propion/Salmeterol | 43 | 1,530 | $9,085.97 | 13 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 38 | 1,800 | $3,535.64 | — |
| Fluticasone Propionate | Fluticasone Propionate | 36 | 1,860 | $2,564.93 | 15 |
| Spiriva Respimat | Tiotropium Bromide | 27 | 1,110 | $18,854.82 | — |
| Advair Hfa | Fluticasone Propion/Salmeterol | 26 | 1,080 | $14,083.89 | — |
| Incruse Ellipta | Umeclidinium Bromide | 20 | 600 | $6,088.22 | — |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | 720 | $5,339.40 | — |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 16 | 1,020 | $15,862.15 | — |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | 570 | $2,255.13 | — |
| Omeprazole | Omeprazole | 13 | 690 | $17.75 | — |
| Famotidine | Famotidine | 13 | 390 | $33.18 | — |
| Arnuity Ellipta | Fluticasone Furoate | 13 | 390 | $3,362.90 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20091023000577
NV
9830236850
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 200 BATH ST, STE 1, CARSON CITY, NV 897032459 (Tel: 7758412100)
Registered at 200 BATH ST, STE 1, CARSON CITY, NV 897032459 (Tel: 7758412100)
NPI status registered as active in NPPES database
Registered at 1007 NORTH CURRY ST, CARSON CITY, NV 89703 (Tel: 7758412100)
Registered at 1007 NORTH CURRY ST, CARSON CITY, NV 89703 (Tel: 7758412100)
Recorded as ERIKA GRAUL, APN
Nurse Practitioner (license number reported to NPPES: NV APN421)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Carson City
- Mallory Cushner, APRN
- Karie Randall, APRN
- Susan Cocores, APRN
- Kimbrelle Pascua, APRN
- Joshua Pierce, APRN-FNP
- Margaretha Schroeder, APN
Mailing Address
200 Bath St, Ste 1
Carson City, NV 897032459
Phone: 7758412100